4Suppliers
7Customers
1Debt Items
20Related Chains

Immatics N.V. Suppliers

TickerNameConfidenceEvidence
GDTC CytoMed Therapeutics Limited 72% Reciprocal relationship from GDTC graph: Reciprocal relationship from IMTX graph: Reciprocal relationship from GDTC graph: Reciprocal relationship from IMTX graph: Reciprocal relationship from GDTC g…
MRNA Moderna, Inc. 72% Reciprocal relationship from MRNA graph: Reciprocal relationship from IMTX graph: Reciprocal relationship from MRNA graph: Reciprocal relationship from IMTX graph: Reciprocal relationship from MRNA g…
TMO Thermo Fisher Scientific Inc. 72% A”) with Patheon UK Limited (“Patheon”), a subsidiary of Thermo Fisher Scientific Inc., for certain manufacturing and quality control services. The Agreement contains customary termination and cancel…
TMO Thermo Fisher Scientific Inc. 72% Reciprocal relationship from TMO graph: Reciprocal relationship from IMTX graph: Reciprocal relationship from TMO graph: Reciprocal relationship from IMTX graph: A”) with Patheon UK Limited (“Patheon…

Immatics N.V. Customers

TickerNameConfidenceEvidence
PATHEON-UK-LIMITED PATHEON-UK-LIMITED 85% A”) with Patheon UK Limited (“Patheon”), a subsidiary of Thermo Fisher Scientific Inc., for certain manufacturing and quality control services. The Agreement contains customary termination and cancel…
TMO Thermo Fisher Scientific Inc. 85% A”) with Patheon UK Limited (“Patheon”), a subsidiary of Thermo Fisher Scientific Inc., for certain manufacturing and quality control services. The Agreement contains customary termination and cancel…
TMO Thermo Fisher Scientific Inc. 85% Reciprocal relationship from TMO graph: Reciprocal relationship from IMTX graph: Reciprocal relationship from TMO graph: Reciprocal relationship from IMTX graph: A”) with Patheon UK Limited (“Patheon…
EDIT Editas Medicine, Inc. 72% expired Service Options outstanding on December 31, Service Options exercisable on December 31, Weighted average remaining contract life (years) Service Options outstanding as of December 31, 2022: F…
EDIT Editas Medicine, Inc. 72% Reciprocal relationship from EDIT graph: Reciprocal relationship from IMTX graph: expired Service Options outstanding on December 31, Service Options exercisable on December 31, Weighted average rema…
GDTC CytoMed Therapeutics Limited 72% Reciprocal relationship from GDTC graph: l expansion. ATPL retained the right to use all products and/or services the Company creates which contain or incorporate the modified human K562 cells. Any n…
MRNA Moderna, Inc. 72% Reciprocal relationship from MRNA graph: tablished a global Environment, Health, and Safety (EHS) organization to foster a safe and healthy work environment with a focus on sustainability and complia…

Immatics N.V. Debt Obligations

InstrumentDescriptionConfidenceEvidence
IMTX-DEBT Debt stack $18.2M 90% Market cache reports total debt of $18.2M.

Immatics N.V. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Immatics N.V..

Immatics N.V. Ownership

HolderNameConfidenceEvidence
IMTX-OWNER-T-ROWE-PRICE-INVESTMENT-MANAGEME T. Rowe Price Investment Management, Inc. 90% 13F overlay lists T. Rowe Price Investment Management, Inc. as top holder; 83 tracked holders.

Immatics N.V. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
GH Guardant Health, Inc. 100.00 2
TKPHF Takeda Pharmaceutical Company Limited 100.00 2
GHRS GH Research PLC 100.00 2
ICLR ICON Public Limited Company 100.00 2
IDXG Interpace Biosciences, Inc. 100.00 2
IPSC Century Therapeutics, Inc. 100.00 2
BTAI BioXcel Therapeutics, Inc. 100.00 2
FATE Fate Therapeutics, Inc. 100.00 2
DAWN Day One Biopharmaceuticals Inc 100.00 2
GILD Gilead Sciences, Inc. 100.00 2
BCAX Bicara Therapeutics Inc. 100.00 2
CRBP Corbus Pharmaceuticals Holdings, Inc. 100.00 2
GMAB Genmab A/S 100.00 2
EDIT Editas Medicine, Inc. 100.00 1 ['customer']
ACET Adicet Bio, Inc. 100.00 2
ALLO Allogene Therapeutics, Inc. 100.00 2
BHPLF BHP Group Limited 100.00 2
BOLT Bolt Biotherapeutics, Inc. 100.00 2
CLLS Cellectis S.A. 100.00 2
AZTA Azenta, Inc. 100.00 2